Диссертация (1145685), страница 24
Текст из файла (страница 24)
Rev. – 1996. – Т. 60 – № 3 – 512–538 p.90. Marrakchi S. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis / S.Marrakchi, P. Guigue, B. R. Renshaw, A. Puel, X.-Y. Pei, S. Fraitag, J. Zribi, E. Bal, C. Cluzeau, M.Chrabieh, J. E. Towne, J. Douangpanya, C. Pons, S. Mansour, V. Serre, H.
Makni, N. Mahfoudh, F.Fakhfakh, C. Bodemer, J. Feingold, S. Hadj-Rabia, M. Favre, E. Genin, M. Sahbatou, A. Munnich, J.L. Casanova, J. E. Sims, H. Turki, H. Bachelez, A. Smahi // N. Engl. J. Med. – 2011. – Т. 365 – № 7 –620–628 p.13691. Martinon F. The inflammasomes: guardians of the body / F. Martinon, A. Mayor, J. Tschopp //Annu.
Rev. Immunol. – 2009. – Т. 27 – 229–265 p.92. Medina-Contreras O. Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage / O.Medina-Contreras, A. Harusato, H. Nishio, K. L. Flannigan, V. Ngo, G. Leoni, P.-A. Neumann, D.Geem, L. N. Lili, R. A. Ramadas, B. Chassaing, A. T.
Gewirtz, J. E. Kohlmeier, C. A. Parkos, J. E.Towne, A. Nusrat, T. L. Denning // J. Immunol. Baltim. Md 1950 – 2015.93. Mehta D. Ultraviolet B Phototherapy for Psoriasis: Review of Practical Guidelines / D. Mehta, H.W. Lim // Am. J. Clin. Dermatol. – 2016. – Т. 17 – № 2 – 125–133 p.94. Milora K.A. Interleukin-36β provides protection against HSV-1 infection, but does not modulateinitiation of adaptive immune responses / K. A. Milora, S. R. Uppalapati, J. C.
Sanmiguel, W. Zou, L.E. Jensen // Sci. Rep. – 2017. – Т. 7 – № 1 – 5799 p.95. Mutamba S. Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs andfacilitates DC maturation by IL-1F8 and IL-1F9 / S. Mutamba, A. Allison, Y. Mahida, P. Barrow, N.Foster // Eur. J. Immunol. – 2012.
– Т. 42 – № 3 – 607–617 p.96. Nicklin M.J.H. A sequence-based map of the nine genes of the human interleukin-1 cluster / M. J.H. Nicklin, J. L. Barton, M. Nguyen, M. G. FitzGerald, G. W. Duff, K. Kornman // Genomics – 2002.– Т. 79 – № 5 – 718–725 p.97. Nolan K.F. The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to theDRD2 gene locus and distinct from mapped IDDM loci / K. F. Nolan, D.
R. Greaves, H. Waldmann //Genomics – 1998. – Т. 51 – № 1 – 161–163 p.98. Onoufriadis A. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatoryskin disease known as generalized pustular psoriasis / A. Onoufriadis, M. A. Simpson, A. E. Pink, P.Di Meglio, C. H. Smith, V.
Pullabhatla, J. Knight, S. L. Spain, F. O. Nestle, A. D. Burden, F. Capon,R. C. Trembath, J. N. Barker // Am. J. Hum. Genet. – 2011. – Т. 89 – № 3 – 432–437 p.99. Pace A.L. Asparagine deamidation dependence on buffer type, pH, and temperature / A. L. Pace,R. L. Wong, Y. T. Zhang, Y.-H. Kao, Y. J. Wang // J. Pharm. Sci. – 2013. – Т. 102 – № 6 – 1712–1723 p.137100. Pan G.
IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp / G. Pan, P.Risser, W. Mao, D. T. Baldwin, A. W. Zhong, E. Filvaroff, D. Yansura, L. Lewis, C. Eigenbrot, W. J.Henzel, R. Vandlen // Cytokine – 2001. – Т. 13 – № 1 – 1–7 p.101.
Papp K. Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the PsoriasisLongitudinal Assessment and Registry (PSOLAR) / K. Papp, A. B. Gottlieb, L. Naldi, D. Pariser, V.Ho, K. Goyal, S. Fakharzadeh, M. Chevrier, S. Calabro, W. Langholff, G.
Krueger // J. DrugsDermatol. JDD – 2015. – Т. 14 – № 7 – 706–714 p.102. Paul C. Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in thetreatment of psoriasis vulgaris: rationale for development and clinical profile / C. Paul, B. Bang, M.Lebwohl // Expert Opin. Pharmacother. – 2017.
– Т. 18 – № 1 – 115–121 p.103. Penha R. IL-36 receptor is expressed by human blood and intestinal T lymphocytes and is dosedependently activated via IL-36β and induces CD4+ lymphocyte proliferation / R. Penha, J. Higgins,S. Mutamba, P. Barrow, Y. Mahida, N. Foster // Cytokine – 2016. – Т.
85 – 18–25 p.104. Piatkov K.I. Formyl-methionine as a degradation signal at the N-termini of bacterial proteins / K.I. Piatkov, T. T. M. Vu, C.-S. Hwang, A. Varshavsky // Microb. Cell – 2015. – Т. 2 – № 10 – 376–393p.105. Podlipnik S. Pneumocystis jirovecii pneumonia in a patient with pustular psoriasis with an IL36RN deficiency treated with infliximab: Case report and review of the literature / S. Podlipnik, L.
dela Mora, M. Alsina, J. M. Mascaró // Australas. J. Dermatol. – 2017. – Т. 58 – № 2 – e44–e47 p.106. Proudfoot A.E. Extension of recombinant human RANTES by the retention of the initiatingmethionine produces a potent antagonist / A. E.
Proudfoot, C. A. Power, A. J. Hoogewerf, M. O.Montjovent, F. Borlat, R. E. Offord, T. N. Wells // J. Biol. Chem. – 1996. – Т. 271 – № 5 – 2599–2603p.107. Rabhi-Essafi I. A strategy for high-level expression of soluble and functional human interferonalpha as a GST-fusion protein in E. coli / I. Rabhi-Essafi, A. Sadok, N.
Khalaf, D. M. Fathallah //Protein Eng. Des. Sel. PEDS – 2007. – Т. 20 – № 5 – 201–209 p.108. Raj D. Keratinocyte apoptosis in epidermal development and disease / D. Raj, D. E. Brash, D.Grossman // J. Invest. Dermatol. – 2006. – Т. 126 – № 2 – 243–257 p.138109. Reichelt P.
Single step protocol to purify recombinant proteins with low endotoxin contents / P.Reichelt, C. Schwarz, M. Donzeau // Protein Expr. Purif. – 2006. – Т. 46 – № 2 – 483–488 p.110. Renert-Yuval Y. IL36RN mutation causing generalized pustular psoriasis in a Palestinian patient /Y. Renert-Yuval, L. Horev, S. Babay, S. Tams, Y. Ramot, A. Zlotogorski, V. Molho-Pessach // Int. J.Dermatol. – 2014.
– Т. 53 – № 7 – 866–868 p.111. Rossi-Semerano L. First clinical description of an infant with interleukin-36-receptor antagonistdeficiency successfully treated with anakinra / L. Rossi-Semerano, M. Piram, C. Chiaverini, D. DeRicaud, A. Smahi, I. Koné-Paut // Pediatrics – 2013.
– Т. 132 – № 4 – e1043-1047 p.112. Ryoo J.Y. Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of PlaquePsoriasis / J. Y. Ryoo, H.-J. Yang, E. Ji, B. K. Yoo // Ann. Pharmacother. – 2016. – Т. 50 – № 5 –341–351 p.113. Saikaly S.K. Biologics and Pediatric Generalized Pustular Psoriasis: An Emerging TherapeuticTrend / S. K.
Saikaly, M. Mattes // Cureus – 2016. – Т. 8 – № 6 – e652 p.114. Salem S.A.M. Bath psoralen+ultraviolet A photochemotherapy vs. narrow band-ultraviolet B inpsoriasis: a comparison of clinical outcome and effect on circulating T-helper and Tsuppressor/cytotoxic cells / S. A. M. Salem, M. A. E.-T. Barakat, C. M.
Z. M. Morcos //Photodermatol. Photoimmunol. Photomed. – 2010. – Т. 26 – № 5 – 235–242 p.115. Scheiermann P. Application of IL-36 receptor antagonist weakens CCL20 expression and impairsrecovery in the late phase of murine acetaminophen-induced liver injury / P. Scheiermann, M.Bachmann, L. Härdle, T. Pleli, A.
Piiper, B. Zwissler, J. Pfeilschifter, H. Mühl // Sci. Rep. – 2015. – Т.5 – 8521 p.116. Schmitz J. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related proteinST2 and induces T helper type 2-associated cytokines / J. Schmitz, A. Owyang, E. Oldham, Y. Song,E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J.
Qin, X. Li, D. M. Gorman, J. F. Bazan,R. A. Kastelein // Immunity – 2005. – Т. 23 – № 5 – 479–490 p.117. Sehgal V.N. Anthralin/dithranol in dermatology / V. N. Sehgal, P. Verma, A. Khurana // Int. J.Dermatol. – 2014. – Т. 53 – № 10 – e449-460 p.139118. Setta-Kaffetzi N. Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associatedpustular phenotypes / N. Setta-Kaffetzi, A. A.
Navarini, V. M. Patel, V. Pullabhatla, A. E. Pink, S.-E.Choon, M. A. Allen, A. D. Burden, C. E. M. Griffiths, M. M. B. Seyger, B. Kirby, R. C. Trembath, M.A. Simpson, C. H. Smith, F. Capon, J. N. Barker // J. Invest. Dermatol. – 2013. – Т. 133 – № 5 –1366–1369 p.119. Sharaf N. Long-range DNA interactions at the IL-1/IL-36/IL-37 gene cluster (2q13) are inducedby activation of monocytes / N. Sharaf, M. J.
Nicklin, F. S. di Giovine // Cytokine – 2014. – Т. 68 – №1 – 16–22 p.120. Shirokov D.A. [Designing of hybrid human interferon alfa-2 strain-producers and the use ofenteropeptidase for obtaining N-terminal methionine-free interferons] / D. A. Shirokov, V. V.Riabichenko, R. I. Akishina, T. P. Ospel’nikova, A. V. Glazunov, G.
G. Chestukhina, V. P. Veĭko //Mol. Biol. (Mosk.) – 2011. – Т. 45 – № 3 – 510–516 p.121. Sims J.E. A new nomenclature for IL-1-family genes / J. E. Sims, M. J. Nicklin, J. F. Bazan, J. L.Barton, S. J. Busfield, J. E. Ford, R. A. Kastelein, S. Kumar, H. Lin, J. J. Mulero, J. Pan, Y. Pan, D. E.Smith, P. R. Young // Trends Immunol. – 2001. – Т. 22 – № 10 – 536–537 p.122. Sims J.E.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
